CAS 2242952-69-6

Formula: C18H19N7O

InChI: InChI=1S/C18H19N7O/c1-3-25(10(2)26)9-15-22-16-12-5-4-11(13-6-7-20-24-13)8-14(12)21-18(19)17(16)23-15/h4-8H,3,9H2,1-2H3,(H2,19,21)(H,20,24)(H,22,23)

InChI key: UHNRLQRZRNKOKU-UHFFFAOYSA-N

SMILES: CCN(CC1=NC2=C(N1)C(=NC3=C2C=CC(=C3)C4=CC=NN4)N)C(=O)C

BMS986299

CAS: 2242952-69-6

BMS986299

Formula: C₁₈H₁₉N₇O

Purezza: 99.5%

Peso molecolare: 349.39

Ref: 54-BUP00997

BMS986299

CAS: 2242952-69-6

BMS986299 is a modulator of NLRP3 with an EC50 of 1.28 μM and can be used in studies about NLRP3 signaling and the treatment of associated diseases.

Formula: C₁₈H₁₉N₇O

Purezza: 99.93% - 99.93%

Colore e forma: White Solid

Peso molecolare: 349.39

Ref: TM-T9572

N-((4-Amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl)methyl)-N-ethylacetamide

CAS: 2242952-69-6

Formula: C₁₈H₁₉N₇O

Purezza: 98%

Colore e forma: Solid

Peso molecolare: 349.3898

Ref: IN-DA023OIR

N-((4-Amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl)methyl)-N-ethylacetamide

CAS: 2242952-69-6

N-((4-Amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl)methyl)-N-ethylacetamide

Formula: C₁₈H₁₉N₇O

Purezza: 99%

Peso molecolare: 349.39

Ref: IN-DG01469650

BMS-986299

CAS: 2242952-69-6

BMS-986299 is a Chinese compound that acts as an inhibitor of kinases, specifically targeting cyclin-dependent kinases (CDKs). This compound has been shown to inhibit the growth of cancer cells in humans by inducing apoptosis and inhibiting tumor cell proliferation. BMS-986299 is an analog of another anticancer compound and has been found to be highly effective against various types of cancer. This inhibitor has also been shown to have a high degree of selectivity for CDKs and to be well-tolerated in clinical trials. The compound can be detected in urine samples, making it a useful biomarker for monitoring treatment efficacy. Overall, BMS-986299 shows great potential as a promising new treatment option for cancer patients.

Formula: C₁₈H₁₉N₇O

Purezza: Min. 95%

Peso molecolare: 349.4 g/mol

Ref: 3D-SPD95269